openPR Logo
Press release

Antibiotic Resistance Market Sales Revenue to Significantly Increase in the Next Few Years

10-12-2021 08:15 AM CET | Health & Medicine

Press release from: Persistence Market Research

Antibiotic Resistance Market Sales Revenue to Significantly

The Antibiotic Resistance Market is expected to be worth US$ 12.6 Bn at a CAGR of 4% between 2021 to 2031. Healthcare is going the “digital” way. In other words, artificial intelligence (AI)-enabled medical devices and telemedicine are the concrete instances of the proliferation of the digital wave in the healthcare industry. This factor would be the one traversing the healthcare vertical in the forecast period.

Antibiotic resistance is one of the biggest public health concerns today. In the U.S., over 2 million people suffer from an antibiotic-resistant infection annually. Growing mortality rate due to these infections has generated a gateway for pharmaceutical manufacturers to develop novel antibiotics. Fighting this threat is a national and public health priority that needs a collaborative approach among healthcare providers and governments. Human overuse of antibiotics leads to the development of antibiotic resistance, which, in turn, demands newer antibiotics.

Escherichia coli and Klebsiella pneumonia are highly resistant to the class of antibiotics called Carbapenem. Carbapenem-resistant Enterobacteriaceae (CRE) infection is a dangerous condition, because these microbes can cause infections in almost all parts of the body. Some of the very severe and common infections include urinary tract infections, ventilator-associated pneumonia bloodstream infections, and intra-abdominal abscesses. These infections are more dangerous as they are resistant to Carbapenem antibiotic drugs, which are considered to be the last resort of defence to treat multidrug-resistant bacterial infections.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/27895

Companies covered in Antibiotic Resistance Market Report
• Pfizer Inc
• GlaxoSmithKline plc
• Merck & Co., Inc.
• Johnsons & Johnson
• Baxter Healthcare Corporation
• Zydus Cadila
• Teva Pharmaceutical Industries Ltd.
• Novartis AG
• Dr. Reddy’s Laboratories Ltd.
• Mayne Pharma Group Limited.
• Sun Pharmaceutical Industries Ltd.
• Cipla Inc.
• Shanghai Pharmaceutical Group Co., Ltd.
• Yuhan Corporation
• Abbott Laboratories

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/27895

Among all the regions, Asia Pacific countries are regarded as high CRE-prevalent regions, where the rate of CRE detection has been continuously increasing.

According to a latest report published by Persistence Market Research, the global antibiotic resistance market is projected to be valued at US$ 12.6 Bn by the end of 2031, witnessing a steady CAGR of over 4% during the forecast period (2021 – 2031).

Key Takeaways from Antibiotic Resistance Market Study

• Beta lactam antibiotics are expected to contribute more than 25% of the revenue share to the market by 2031. These antibiotics target a broad range of microbes, leading to their higher adoption.
• By distribution channel, hospitals pharmacies will lead by acquiring more than half of the market share. Most antibiotic-resistant infections are hospital-acquired, and hence, hospitals are major treatment providers.
• By indication, complicated urinary tract infections (CUTIs) are expected to dominate the market, owning to their higher prevalence, especially in the female population. These infections are common in developing regions with poor hygiene practices.
• North America represents the largest regional market for antibiotic resistance, with one-fourth global market share.
• Key players are focused on strengthening their clinical pipelines with new discoveries of antibiotics and combination therapies.
• The COVID-19 outbreak moderately affected the market. Demand for antibiotics during lockdowns was low as the sole focus was attending COVID-19 patients.
• Demand for antibiotics in Asia Pacific countries, especially India and China, is unmatched. Antibiotic usage in overwhelming in these countries, leading to increased rates of antibiotic resistance, expected to expand at CAGRs above 5% through 2031.
• The U.S. market holds a major share accounting more than 90% of the total North America market.

“Emergence of multi-drug-resistant bacteria due to excess consumption of antibiotics is anticipated to accelerate antibiotic resistance market growth,” says an analyst of Persistence Market Research.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/27895

Strategic Partnerships and Funding by Key Players Aiding Market Expansion

Prominent leaders in the antibiotics industry have pledged to fund a significant amount to bolster the research & development of new antibiotics.
• For instance, Pfizer has assured to invest US$ 100 Mn in R&D of novel antibiotic discovery. This investment will go into its Antimicrobial Resistance (AMR) Action Fund.
• Novartis partnered with over 20 prominent pharmaceutical companies to tackle antibiotic resistance by contributing to the Antimicrobial Resistance (AMR) Action Fund.


What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the antibiotic resistance market in its latest study, presenting historical demand assessment of 2016 – 2020 and projections for 2021 – 2031, on the basis of drug class (beta lactam antibiotic, cephalosporin, quinolones antibiotics, macrolide antibiotics, tetracycline, oxazolidinones and others), by pathogen, (staphylococcus aureus, streptococcus pneumonia, neisseria gonorrhoeae, enterococcus faecium, escherichia coli, klebsiella pneumonia, shigella, clostridium difficile, and others), disease (community acquired bacterial pneumonia (CABP), hospital acquired bacterial pneumonia/ ventilator (HABP/VABP), complicated urinary tract infections (CUTI), complicated intra-abdominal infections (CIAI), blood stream infections (BSI), abdominal infection and diarrhoea [clostridium difficile infections (CDI) & shigella], acute bacterial skin and skin structure infections (ABSSSI), and drug resistant gonorrhoeae), mechanism of action (Cell wall synthesis inhibitors, protein synthesis inhibitors, DNA synthesis inhibitors, RNA synthesis inhibitors and others), and distribution channel (hospitals pharmacies, retail pharmacies, and online pharmacies), across seven key regions of the world.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

About us:

Persistence Market Research is always way ahead of its time. In other words, it tables market solutions by stepping into the companies’/clients’ shoes much before they themselves have a sneak pick into the market. The pro-active approach followed by experts at Persistence Market Research helps companies/clients lay their hands on techno-commercial insights beforehand, so that the subsequent course of action could be simplified on their part.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antibiotic Resistance Market Sales Revenue to Significantly Increase in the Next Few Years here

News-ID: 2425298 • Views:

More Releases from Persistence Market Research

Fruit Ingredients Market to Reach US$ 111.3 Bn by 2032, Driven by Rising Health Trends
Fruit Ingredients Market to Reach US$ 111.3 Bn by 2032, Driven by Rising Health …
Overview of the Global Fruit Ingredients Market The global fruit ingredients market is witnessing significant growth, driven by rising consumer demand for natural, clean-label, and nutrient-rich food products. In 2025, the market is likely to be valued at US$ 75.0 billion and is expected to reach US$ 111.3 billion by 2032, registering a robust CAGR of 5.8% during the forecast period. Fruit ingredients, which include fruit concentrates, purees, powders, and extracts,
Vegan Dessert Market to Reach US$ 11.9 Bn by 2032, Driven by Rising Health & Plant-Based Demand
Vegan Dessert Market to Reach US$ 11.9 Bn by 2032, Driven by Rising Health & Pla …
Overview of the Market The global vegan dessert market is poised for significant expansion, with an estimated valuation of US$ 5.2 billion in 2025, projected to reach US$ 11.9 billion by 2032. This robust growth reflects a compound annual growth rate (CAGR) of 11.7% during the forecast period from 2025 to 2032. Increasing consumer awareness about health, environmental sustainability, and ethical food consumption is driving the widespread adoption of vegan dessert
Instant Beverage Premix Market to Reach US$148.3 Bn by 2032 Driven by Convenience & Demand
Instant Beverage Premix Market to Reach US$148.3 Bn by 2032 Driven by Convenienc …
Overview of the Global Instant Beverage Premix Market The global instant beverage premix market has witnessed remarkable growth over the past decade, driven by evolving consumer lifestyles and increasing demand for convenient, ready-to-consume beverages. Instant beverage premixes, encompassing products such as instant coffee, tea, flavored drinks, protein powders, and nutritional supplements, cater to busy consumers seeking quick preparation without compromising on taste or nutritional value. These premixes have gained popularity across
Dermacosmetics Market to Reach US$ 87.3 Bn by 2032 at 7.4% CAGR: Persistence Market Research
Dermacosmetics Market to Reach US$ 87.3 Bn by 2032 at 7.4% CAGR: Persistence Mar …
The global dermacosmetics market, estimated at US$ 53 billion in 2025, is forecasted to witness a steady upward trajectory, expanding at a Compound Annual Growth Rate (CAGR) of 7.4% to reach US$ 87.3 billion by 2032. This surge is driven by a confluence of factors ranging from increasing consumer awareness and the rising incidence of skin conditions to a growing preference for advanced, dermatologist-backed skincare solutions. Dermacosmetics, a category that

All 5 Releases


More Releases for Antibiotic

Emerging Trends Influencing The Growth Of The Antibiotic Resistance Market:Produ …
The Antibiotic Resistance Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. How Big Is the Antibiotic Resistance Market Size Expected to Be by 2034? The Antibiotic Resistance Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034.
Antibiotic Resistance Market: An In-Depth Analysis
Introduction: Antibiotic resistance, the ability of bacteria and other microorganisms to resist the effects of an antibiotic, has become a significant global health threat. This growing concern has led to a sharp rise in the demand for new antibiotics, alternative treatments, and robust diagnostic tools. The antibiotic resistance market encompasses a range of solutions aimed at combating this challenge, including the development of novel antibiotics, rapid diagnostic tests, and antimicrobial stewardship
Ruminant Feed Antibiotic Market Size | Emerging Growth 2033
The new report published by The Business Research Company, titled ""Ruminant Feed Antibiotics Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends. As per the report, the ruminant feed antibiotics market size has grown strongly in recent years. It will grow from $5.06
Antibiotic Resistance Market Size, CAGR | Trend 2030
Exclusive Report by Ameco Research: Antibiotic Resistance Market Size Projected to Reach USD 15 Billion by 2030, Growing at 5.20% CAGR Ameco Research is proud to announce the launch of its latest market research report, Antibiotic Resistance Market. This comprehensive report provides in-depth analysis and insights into the current market trends and future projections in the Industry/Market Segment. Ameco Research has been at the forefront of providing quality market research
Antibiotic Resistance Market Industry Analysis - Antibiotic Resistance Market Si …
The global antibiotic resistance market was valued around US$ 15.2 Billion in 2030 and is anticipated to expand at a stable CAGR above 5.5% during the forecast period 2022 to 2030. According to the report titled "Antibiotic Resistance Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2022-2030". Emergence of multi-drug resistant pathogens, growing need to prevent antibiotic effects and rise in incidences of chronic and infectious diseases
Antibiotic Assay Discs Market 2022 | Detailed Report
The market report delivers an all-inclusive analysis of the market structure along with a forecast of the various segments and sub-segments of the Antibiotic Assay Discs industry. This wide-ranging market research report acts as a backbone for the success of business in any niche. The Antibiotic Assay Discs market survey report has been prepared by conducting market research in a systematic manner. Moreover, the Antibiotic Assay Discs report includes a